VALCHLOR® (mechlorethamine) gel is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides–type cutaneous T-cell lymphoma (MF-CTCL) in patients who have received prior skin-directed therapy

Treatment that fits into your patient's daily routine1

VALCHLOR* is a clear, topical, quick-drying formulation of mechlorethamine for the treatment of Stage IA/IB mycosis fungoides–type cutaneous T-cell lymphoma (MF-CTCL) that can be applied in the comfort of home1

O D icon

Once-daily self-administration1

Applied at home by the patient or a caregiver

Chronometer icon

Quick drying1

5 to 10 minutes after application

Soap bottle icon

Can be used with emollients1

2 hours before or 2 hours after application

Shirt icon

Clear, non-greasy gel1

Once dry, unlikely to stain clothing or sheets

See special handling and disposal considerations for VALCHLOR

  • VALCHLOR is flammable. Patients should avoid fire, flame, and smoking until VALCHLOR has dried1
  • Mechlorethamine is an alkylating agent that inhibits rapidly proliferating cells1

*Each tube of VALCHLOR gel contains gel 0.016% w/w of mechlorethamine (equivalent to 0.02% mechlorethamine HCl).1

There is no FDA-approved therapeutic equivalent for VALCHLOR2